DXA Study of Precision and Reliability
Launched by PENN STATE UNIVERSITY · Aug 3, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the DXA Study of Precision and Reliability, is looking at how accurate and consistent different scanning machines are when measuring bone health and body composition. The study will test three types of scanners to see how well they perform in various situations, like different days, different technicians, and variations in how people are positioned during the scans. The goal is to understand how much the results can change and to create a database that helps ensure the quality of these tests in the future.
To participate in this study, you need to be a healthy adult aged 18-40 or over 40, and there are some criteria that might exclude you, such as being pregnant, having certain medical devices, or weighing over 450 lbs. If you join, you'll undergo scans that measure your bone and soft tissue health, and the results will help improve the reliability of these important tests. The study is currently recruiting participants, and everyone is welcome to apply, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adults of two age groups, 1) aged 18-40 or 2) aged \>40yr.
- Exclusion Criteria:
- • 1. for females, being pregnant
- • 2. Having had X-ray procedures using contrast material in the previous 3 days
- • 3. Having medical devices that interfere with scan accuracy
- • 4. Wearing external metal objects that cannot be removed
- • 5. Having internal metal objects
- • 6. Body mass of \> 450 lbs.
- • 7. Having ostomies
About Penn State University
Penn State University is a leading research institution renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical trials. As a prominent sponsor of clinical research, the university leverages its diverse expertise across various medical fields to conduct rigorous studies aimed at evaluating new treatments, interventions, and healthcare strategies. With a strong emphasis on collaboration, ethical standards, and patient safety, Penn State University is dedicated to translating research findings into real-world applications that enhance the well-being of communities and contribute to the broader scientific landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
University Park, Pennsylvania, United States
Patients applied
Trial Officials
Mary Jane De Souza, PhD
Principal Investigator
Penn State
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials